PAREXEL Expands Global Clinical Logistics Ca...( Companies can avoid developing the...)

Companies can avoid developing their own internal systems and managing multiple vendors by taking advantage of PAREXEL's global team of experts

and distribution infrastructure

BOSTON, June 19 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services organization, today announced that it is expanding its clinical logistics capabilities to help clients more effectively manage their global clinical trial supply requirements. PAREXEL's Clinical Logistics Services provide centralized coordination of clinical study supplies, lab services, and ancillary supplies worldwide. Capabilities include a distribution and warehousing infrastructure to properly handle and transport clinical study supplies to locations worldwide, and sophisticated technology systems to track shipments and inventory levels. The global clinical logistics team, with in-depth expertise in import and export regulations, oversees and coordinates multinational logistics.

"One of the most frequently reported causes of study delays is the lack of available study drug caused by late or incomplete arrival of clinical supplies. These problems can result in costly delays and cause critical milestones to be missed," said Mark A. Goldberg, M.D., President of Clinical Research Services and Perceptive Informatics, PAREXEL. "With growing study complexity and increasing globalization of clinical research, biopharmaceutical companies need to fully integrate clinical logistics into study design and execution. PAREXEL is responding to client needs by continuing to provide end-to-end management of clinical logistics, with a focus on reliable delivery of study-related supplies."

"Specialized
'/>"/>